Arm span as measurement of response to growth hormone (GH) treatment in a group of children with meningomyelocele and GH deficiency

Children with meningomyelocele (MMC) frequently have impaired linear growth. A number have associated structural brain defects with resultant GH deficiency (GHD). Reproducible measurements of height or length in MMC patients are often hampered by lower limb contractures, spasticity, and scoliosis. A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of clinical endocrinology and metabolism 1996-04, Vol.81 (4), p.1654-1656
Hauptverfasser: SATIN-SMITH, M. S, KATZ, L. L, THORNTON, P, GRUCCIO, D, MOSHANG, T. JR
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1656
container_issue 4
container_start_page 1654
container_title The journal of clinical endocrinology and metabolism
container_volume 81
creator SATIN-SMITH, M. S
KATZ, L. L
THORNTON, P
GRUCCIO, D
MOSHANG, T. JR
description Children with meningomyelocele (MMC) frequently have impaired linear growth. A number have associated structural brain defects with resultant GH deficiency (GHD). Reproducible measurements of height or length in MMC patients are often hampered by lower limb contractures, spasticity, and scoliosis. Arm span has been proposed as a more reproducible measure of linear growth. Five MMC children documented to have GHD were treated with recombinant human GH (hGH) for 1-3 yr. Their height, arm span, and growth velocity were compared with 32 children with idiopathic GHD treated similarly with hGH. These measures are compared with normal children by being expressed as standard deviation scores. The results of this study indicate that arm span measurements in GHD MMC patients are almost identical to height measurements in idiopathic GHD patients both before and during hGH therapy. The physical condition of children with MMC makes reproducible longitudinal height measurements difficult. Routine determinations of arm span measurements for children with MMC will assist in recognizing growth failure as well as monitoring treatment results.
doi_str_mv 10.1210/jc.81.4.1654
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77986861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77986861</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-7ea4c04b6b0772736186a34a7d530f6d3ea5fbaeee6ec76870ed8f94fc5f4e8a3</originalsourceid><addsrcrecordid>eNo90MFrFDEUBvAglrpWb16FHEQUOmsyySSZYym6KxS8tOAtvM28dLPMJGMyQ9mz_7izdunpHd7vezw-Qj5wtuY1Z98Obm34Wq65auQrsuKtbCrNW_2arBiredXq-vcb8raUA2NcykZckkujhBJGrMjfmzzQMkKkUOiAUOaMA8aJJk8zljHFgnRK9DGnp2lP9ykPKSL9stl-pVNGmP7jsMRPZB5PObcPfZcx0qewRBYQ4mMajtgnhz1SiB3dbGmHPriA0R3fkQsPfcH353lFHn58v7_dVne_Nj9vb-4qJ3gzVRpBOiZ3ase0rrVQ3CgQEnTXCOZVJxAavwNEVOi0MpphZ3wrvWu8RAPiinx-vjvm9GfGMtkhlOWlHiKmuVitW6OM4gu8foYup1IyejvmMEA-Ws7sqXN7cNZwK-2p84V_PN-ddwN2L_hc8rL_dN5DcdD7DNGF8sIEk62qa_EPfgmLbQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77986861</pqid></control><display><type>article</type><title>Arm span as measurement of response to growth hormone (GH) treatment in a group of children with meningomyelocele and GH deficiency</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>SATIN-SMITH, M. S ; KATZ, L. L ; THORNTON, P ; GRUCCIO, D ; MOSHANG, T. JR</creator><creatorcontrib>SATIN-SMITH, M. S ; KATZ, L. L ; THORNTON, P ; GRUCCIO, D ; MOSHANG, T. JR</creatorcontrib><description>Children with meningomyelocele (MMC) frequently have impaired linear growth. A number have associated structural brain defects with resultant GH deficiency (GHD). Reproducible measurements of height or length in MMC patients are often hampered by lower limb contractures, spasticity, and scoliosis. Arm span has been proposed as a more reproducible measure of linear growth. Five MMC children documented to have GHD were treated with recombinant human GH (hGH) for 1-3 yr. Their height, arm span, and growth velocity were compared with 32 children with idiopathic GHD treated similarly with hGH. These measures are compared with normal children by being expressed as standard deviation scores. The results of this study indicate that arm span measurements in GHD MMC patients are almost identical to height measurements in idiopathic GHD patients both before and during hGH therapy. The physical condition of children with MMC makes reproducible longitudinal height measurements difficult. Routine determinations of arm span measurements for children with MMC will assist in recognizing growth failure as well as monitoring treatment results.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.81.4.1654</identifier><identifier>PMID: 8636383</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adolescent ; Anthropometry - methods ; Arm ; Biological and medical sciences ; Biomarkers - blood ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Growth - drug effects ; Growth - physiology ; Growth Hormone - blood ; Growth Hormone - deficiency ; Growth Hormone - therapeutic use ; Humans ; Insulin-Like Growth Factor Binding Protein 3 - blood ; Insulin-Like Growth Factor I - analysis ; Longitudinal Studies ; Male ; Malformations of the nervous system ; Medical sciences ; Meningomyelocele - complications ; Meningomyelocele - drug therapy ; Meningomyelocele - physiopathology ; Neurology ; Recombinant Proteins - therapeutic use ; Reproducibility of Results</subject><ispartof>The journal of clinical endocrinology and metabolism, 1996-04, Vol.81 (4), p.1654-1656</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-7ea4c04b6b0772736186a34a7d530f6d3ea5fbaeee6ec76870ed8f94fc5f4e8a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3049622$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8636383$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SATIN-SMITH, M. S</creatorcontrib><creatorcontrib>KATZ, L. L</creatorcontrib><creatorcontrib>THORNTON, P</creatorcontrib><creatorcontrib>GRUCCIO, D</creatorcontrib><creatorcontrib>MOSHANG, T. JR</creatorcontrib><title>Arm span as measurement of response to growth hormone (GH) treatment in a group of children with meningomyelocele and GH deficiency</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Children with meningomyelocele (MMC) frequently have impaired linear growth. A number have associated structural brain defects with resultant GH deficiency (GHD). Reproducible measurements of height or length in MMC patients are often hampered by lower limb contractures, spasticity, and scoliosis. Arm span has been proposed as a more reproducible measure of linear growth. Five MMC children documented to have GHD were treated with recombinant human GH (hGH) for 1-3 yr. Their height, arm span, and growth velocity were compared with 32 children with idiopathic GHD treated similarly with hGH. These measures are compared with normal children by being expressed as standard deviation scores. The results of this study indicate that arm span measurements in GHD MMC patients are almost identical to height measurements in idiopathic GHD patients both before and during hGH therapy. The physical condition of children with MMC makes reproducible longitudinal height measurements difficult. Routine determinations of arm span measurements for children with MMC will assist in recognizing growth failure as well as monitoring treatment results.</description><subject>Adolescent</subject><subject>Anthropometry - methods</subject><subject>Arm</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Growth - drug effects</subject><subject>Growth - physiology</subject><subject>Growth Hormone - blood</subject><subject>Growth Hormone - deficiency</subject><subject>Growth Hormone - therapeutic use</subject><subject>Humans</subject><subject>Insulin-Like Growth Factor Binding Protein 3 - blood</subject><subject>Insulin-Like Growth Factor I - analysis</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Malformations of the nervous system</subject><subject>Medical sciences</subject><subject>Meningomyelocele - complications</subject><subject>Meningomyelocele - drug therapy</subject><subject>Meningomyelocele - physiopathology</subject><subject>Neurology</subject><subject>Recombinant Proteins - therapeutic use</subject><subject>Reproducibility of Results</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90MFrFDEUBvAglrpWb16FHEQUOmsyySSZYym6KxS8tOAtvM28dLPMJGMyQ9mz_7izdunpHd7vezw-Qj5wtuY1Z98Obm34Wq65auQrsuKtbCrNW_2arBiredXq-vcb8raUA2NcykZckkujhBJGrMjfmzzQMkKkUOiAUOaMA8aJJk8zljHFgnRK9DGnp2lP9ykPKSL9stl-pVNGmP7jsMRPZB5PObcPfZcx0qewRBYQ4mMajtgnhz1SiB3dbGmHPriA0R3fkQsPfcH353lFHn58v7_dVne_Nj9vb-4qJ3gzVRpBOiZ3ase0rrVQ3CgQEnTXCOZVJxAavwNEVOi0MpphZ3wrvWu8RAPiinx-vjvm9GfGMtkhlOWlHiKmuVitW6OM4gu8foYup1IyejvmMEA-Ws7sqXN7cNZwK-2p84V_PN-ddwN2L_hc8rL_dN5DcdD7DNGF8sIEk62qa_EPfgmLbQ</recordid><startdate>19960401</startdate><enddate>19960401</enddate><creator>SATIN-SMITH, M. S</creator><creator>KATZ, L. L</creator><creator>THORNTON, P</creator><creator>GRUCCIO, D</creator><creator>MOSHANG, T. JR</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960401</creationdate><title>Arm span as measurement of response to growth hormone (GH) treatment in a group of children with meningomyelocele and GH deficiency</title><author>SATIN-SMITH, M. S ; KATZ, L. L ; THORNTON, P ; GRUCCIO, D ; MOSHANG, T. JR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-7ea4c04b6b0772736186a34a7d530f6d3ea5fbaeee6ec76870ed8f94fc5f4e8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adolescent</topic><topic>Anthropometry - methods</topic><topic>Arm</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Growth - drug effects</topic><topic>Growth - physiology</topic><topic>Growth Hormone - blood</topic><topic>Growth Hormone - deficiency</topic><topic>Growth Hormone - therapeutic use</topic><topic>Humans</topic><topic>Insulin-Like Growth Factor Binding Protein 3 - blood</topic><topic>Insulin-Like Growth Factor I - analysis</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Malformations of the nervous system</topic><topic>Medical sciences</topic><topic>Meningomyelocele - complications</topic><topic>Meningomyelocele - drug therapy</topic><topic>Meningomyelocele - physiopathology</topic><topic>Neurology</topic><topic>Recombinant Proteins - therapeutic use</topic><topic>Reproducibility of Results</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SATIN-SMITH, M. S</creatorcontrib><creatorcontrib>KATZ, L. L</creatorcontrib><creatorcontrib>THORNTON, P</creatorcontrib><creatorcontrib>GRUCCIO, D</creatorcontrib><creatorcontrib>MOSHANG, T. JR</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SATIN-SMITH, M. S</au><au>KATZ, L. L</au><au>THORNTON, P</au><au>GRUCCIO, D</au><au>MOSHANG, T. JR</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Arm span as measurement of response to growth hormone (GH) treatment in a group of children with meningomyelocele and GH deficiency</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>1996-04-01</date><risdate>1996</risdate><volume>81</volume><issue>4</issue><spage>1654</spage><epage>1656</epage><pages>1654-1656</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Children with meningomyelocele (MMC) frequently have impaired linear growth. A number have associated structural brain defects with resultant GH deficiency (GHD). Reproducible measurements of height or length in MMC patients are often hampered by lower limb contractures, spasticity, and scoliosis. Arm span has been proposed as a more reproducible measure of linear growth. Five MMC children documented to have GHD were treated with recombinant human GH (hGH) for 1-3 yr. Their height, arm span, and growth velocity were compared with 32 children with idiopathic GHD treated similarly with hGH. These measures are compared with normal children by being expressed as standard deviation scores. The results of this study indicate that arm span measurements in GHD MMC patients are almost identical to height measurements in idiopathic GHD patients both before and during hGH therapy. The physical condition of children with MMC makes reproducible longitudinal height measurements difficult. Routine determinations of arm span measurements for children with MMC will assist in recognizing growth failure as well as monitoring treatment results.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>8636383</pmid><doi>10.1210/jc.81.4.1654</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-972X
ispartof The journal of clinical endocrinology and metabolism, 1996-04, Vol.81 (4), p.1654-1656
issn 0021-972X
1945-7197
language eng
recordid cdi_proquest_miscellaneous_77986861
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Anthropometry - methods
Arm
Biological and medical sciences
Biomarkers - blood
Child
Child, Preschool
Female
Follow-Up Studies
Growth - drug effects
Growth - physiology
Growth Hormone - blood
Growth Hormone - deficiency
Growth Hormone - therapeutic use
Humans
Insulin-Like Growth Factor Binding Protein 3 - blood
Insulin-Like Growth Factor I - analysis
Longitudinal Studies
Male
Malformations of the nervous system
Medical sciences
Meningomyelocele - complications
Meningomyelocele - drug therapy
Meningomyelocele - physiopathology
Neurology
Recombinant Proteins - therapeutic use
Reproducibility of Results
title Arm span as measurement of response to growth hormone (GH) treatment in a group of children with meningomyelocele and GH deficiency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T14%3A18%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Arm%20span%20as%20measurement%20of%20response%20to%20growth%20hormone%20(GH)%20treatment%20in%20a%20group%20of%20children%20with%20meningomyelocele%20and%20GH%20deficiency&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=SATIN-SMITH,%20M.%20S&rft.date=1996-04-01&rft.volume=81&rft.issue=4&rft.spage=1654&rft.epage=1656&rft.pages=1654-1656&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.81.4.1654&rft_dat=%3Cproquest_cross%3E77986861%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77986861&rft_id=info:pmid/8636383&rfr_iscdi=true